This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08542/identifier/chemspider/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08542/identifier/pdb/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08542/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08542/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08542/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08542
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB08542 n14:DB08542
dcterms:title
3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione
adms:identifier
n6:389410 n7:440483 n8:99445013 n9:DB08542 n10:SDT
n3:IUPAC-Name
n4:271B6236-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B623C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B623B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6238-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6239-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B623A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6234-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6235-363D-11E5-9242-09173F13E4C5 n4:271B6232-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6233-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B6242-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6243-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B623D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B623E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B6240-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B623F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6241-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B6248-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B624A-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B624B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6247-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6246-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6249-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6237-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6244-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6245-363D-11E5-9242-09173F13E4C5